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 Summary
	 Background:  Tuberous	 sclerosis	 complex	 (TSC)	 is	 an	 autosomal	 dominant	 multisystem	 disorder	 with	
gene	 loci	 located	 on	 chromosomes	 9q34	 (TSC1)	 and	 16p13	 (TSC2).	 Brain	 is	 the	most	 frequently	
affected	organ.	
	 	 We	retrospectively	reviewed	magnetic	resonance	features	of	the	brain	in	92	patients	with	tuberous	
sclerosis,	examined	in	our	Institute	from	1997	to	2006.
 Material/Methods:  We	analyzed	MR	 imaging	of	 the	 spectrum	of	 supra-	 and	 infratentorial	brain	 lesions	 encountered	
in	TSC.	 MR	 examinations	 were	 performed	 with	 a	 1.5	 T	 scanner.	 The	 basic	 imaging	 protocol	
included	axial	 SE	T1WI,	FSE	PD,	T2WI,	FSE	FLAIR	 images,	 sagittal	T1,T2WI	and	coronal	FLAIR	
images.	Axial	T1-WI	contrast-enhanced	images	were	obtained	in	each	patient.
	 Results:	 Cortical	tubers	were	found	in	89	of	the	92	patients	(96.74%)	and	they	have	been	located	in	frontal	
and	parietal	cerebral	lobes	predominantly.	Cerebellar	tubers	were	found	in	12/92	(13.04%),	cerebral	
white	matter	 lesions	 in	34/92	patients	 (36.96%),	subependymal	nodules	 in	80/92	patients	 (86.96%)	
and	 subependymal	 giant	 cell	 astrocytomas	 in	 11/92	 of	 our	 patients	 (11.96%).	 Partial	 agenesis	 of	
corpus	callosum,	cortical	dysplasia,	cerebellar	atrophy,	intracranial	arterial	aneurysm,	enlargement	
of	ventricles	and	venous	malformation	were	rare	associated	findings.	Administration	of	gadolinium	
was	useful	in	detecting	and	delineation	subependymal	giant	cell	astrocytomas	-	SGCAs.
	 Conclusions:  Our	study	presents	a	wide	range	of	MR	signs	and	variance	of	the	cerebral	manifestations	with	TSC	
patients.	
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Background
Tuberous	 sclerosis	 complex	 is	 a	 congenital	 neurocutaneus	
syndrome	also	known	as	Bourneville	disease,	characterized	by	
widespread	development	of	hamartoma	in	multiple	organs.	
Although	 is	 an	 autosomal	 dominant	 disorder,	 up	 to	
60%-70%	of	affected	patients	have	spontaneous	mutations.	
This	disorder	caused	by	mutations	 in	 two	different	genes:	
TSC1	on	chromosome	9q34	and	TSC2	on	16p13.	They	code	
for	 proteins,	 hamartin	 and	 tuberin	 respectively,	 which	
are	 tumor	 suppressors.	 Gene	 mutations	 in	 either	 of	 the	
two	TSC	genes	 result	 in	 abnormal	 cell	 differentiation	and	
deregulated	control	of	cell	size	 [1].	These	cells	migrated	in	
an	atypical	way	to	the	cortex,	consequently	in	TSC	there	is	
evidence	of	widespread	cortical	disorganization	and	struc-
tural	abnormalities	throughout	the	brain.
Diagnostic	 criteria	 for	 tuberous	 sclerosis	 complex	 have	
been	set	out	by	Roach	et	al.	[2].	Hamartomas,	the	hallmark	
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of	 the	 disease,	 are	 found	 in	multiple	 organs:	 the	 brain,	
kidneys,	 lung,	 skin,	 heart.	 Brain	 is	 the	most	 commonly	
affected	organ.	Four	major	cerebral	 findings	are:	cortical	
tubers,	white	matter	 abnormalities,	 subependymal	 nod-
ules,	subependymal	giant	cell	astrocytomas	–	SGCAs.	The	
most	common	neurological	symptoms	are	seizures,	mental	
retardation,	autism,	hyperactivity,	spastic	paralysis,	atax-
ia.	More	 than	 75%	of	 patients	 suffer	 from	 seizures,	 and	
68%	have	mild	to	severe	cognitive	impairment.	As	a	rule,	
larger	 and	more	numerous	 cortical	 tubers	 are	 associated	
with	earlier	seizure	onset	and	more	severe	mental	 retar-
dation	[2,	3,	4].	
Magnetic	resonance	imaging	is	considered	as	the	most	sen-
sitive	 imaging	 technique	 which	 allows	 identification	 of	
	typical	and	atypical	findings.
Materials and methods
We	retrospectively	 reviewed	 the	magnetic	 resonance	 (MR)	
examinations	of	92	patients	who	met	the	criteria	necessary	
for	a	definite	diagnosis	of	TSC.	
48	 were	 male	 (52.2%)	 and	 44	 female	 (47.8%).	 Their	 age	
varied	from	25	days	to	28	years,	(mean	9.3	years).
Some	findings	in	30	of	these	patients	were	described	in	pre-
vious	reports	[5,	6,	7].	
All	 exams	were	 performed	 in	 our	 Institute	 from	1997	 to	
2006.
MR	examinations	were	acquired	with	a	1.5T	scanner.	The	
basic	 imaging	 protocol	 included	 axial	 images:	 SE	 T1WI	
(500-670/16/1-2	 [TR-repetition	 time/TE-echo	 time/exci-
tations]),	 FSE	 PD,	 T2WI	 (15/80/3500-3800/1),	 FSE	 FLAIR	
(1800/13700/112/1-2)	 [IR-inversion	time/TR/TE/excitations],	
sagittal	T1,	T2WI	and	 coronal	 FLAIR	 images.	Matrix	 size	
was	 256x256	 and	256x192,	 field	 of	 view:	 22-23	mm,	 sec-
tion	thickness	4-5	mm,	intersection	gap	1	mm.	
T1-weighted	axial	contrast-enhanced	images	were	obtained	
in	each	patient	 (Gd-DTPA	was	administered	 intravenously	
in	a	standard	dose	of	0.1mmol/L	per	kilogram).	
We	 presented	 a	 systematic	 cerebral	 MR	 evaluation	 and	
analyzed	our	MR	examinations	to	record	supra-	and	infra-
tentorial	 brain	 lesions:	 cortical/subcortical	 tubers,	white	
matter	 abnormalities,	 subependymal	nodules	 (SENs),	 sub-
ependymal	giant	cell	astrocytomas	-	SGCAs.	
Partial	agenesis	of	corpus	callosum,	cortical	dysplasia,	cere-
bellar	atrophy,	intracranial	arterial	aneurysm,	enlargement	
of	 ventricles	 and	 venous	 malformation	 were	 associated	
	findings.
We	quantified	 the	number,	 sites	of	 cortical	 tubers	 in	each	
cerebral	lobe	separately,	reviewed	all	sequences	and	planes.	
The	number	of	white	matter	lesions,	subependymal	nodules	
and	subependymal	giant	cell	astrocytomas	were	quantified	
by	an	absolute	count.	
All	these	findings	were	evaluated	for	the	presence	or	absen-
ce	of	enhancement.
The	signal	intensity	of	these	lesions	also	was	evaluated.
Results
Cortical tubers
We	diagnosed	 cortical	 tubers	 as	 lesions	 caused	by	 gyral	
expansion	 or	 distortion	 with	 abnormal	 signal	 inten-
sity	 on	 T2WI	 and	 FLAIR	 sequence.	 Cortical/subcorti-
cal	 cerebral	 tubers	were	 found	 in	 89	 of	 the	 92	patients	
(96.74%).	In	3	(3/89,	3.37%)	patients	tubers	were	unilate-
ral	 (on	 the	 right	 hemisphere).	 Solely	 cerebral	 tuber	was	
not	seen.
Precisely	brain	location	and	number	of	cerebral	tubers	are	
presented	in	table	1.
A	total	of	1552	tubers	were	found	in	89	patients.	They	were	
most	 commonly	 in	 the	 frontal	 lobes,	 but	 also	 in	 parietal,	
occipital	 and	 temporal	 lobes.	 825	 tubers	were	 right-sided	
and	727	tubers	were	left-sided.	
Cerebral	tubers	showed	high	signal	intensity	on	FLAIR	ima-
ges	in	all	89	patients	(100%),	and	in	19	cases	(19/89,	21.35%)	
we	 found	 hypointense	 signal	 of	 central	 part	 of	 some	
tubers.	Fig	1.
Cerebellar	 tubers	 were	 found	 in	 12	 of	 the	 92	 patients	
(13.04%),	with	total	of	21	lesions	(11	in	the	right	and	10	in	
the	left	cerebellar	hemisphere).	All	cerebellar	tubers	revea-
led	high	signal	intensity	in	FLAIR	images.
Contrast	 enhancement	 revealed	 no	 cerebral	 tubers,	 11	
(11/21,52.38%)	cerebellar	tubers	were	revealed	by	contrast	
enhancement.	Fig	2.
Table 1. Location and number of supratentorial cortical tubers.
Brain lobe right hemisphere left hemisphere
Total  Total 
Frontal lobe 421 0 – 13 (mean 4.6) 357 0 – 13 (mean 3.9)
Parietal lobe 204 0 – 8 (mean 2.2) 193 0 – 6 (mean 2.1)
Occipital lobe 89 0 – 4 (mean 0.9) 93 0 – 3 (mean 1.0)
Temporal lobe 111 0 – 4 (mean 1.2) 84 0 – 3 (mean 0.9)
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White matter abnormalities
We	 defined	white	matter	 lesions	 as	 linear	 abnormalities	
oriented	 from	 the	ventricular	wall	 to	 the	 cortical	 surface	
(radial	 bands),	 or	 presence	 of	 focal,	 nodular,	 tumeafective	
lesions,	or	as	parenchymal	cysts.
Cerebral	white	matter	 lesions	were	 found	 in	 34	 of	 the	 92	
patients	(36.96%).
The	cerebral	white	matter	lesions	were	linear	with	a	radial	
distribution	in	14	cases	(14/34,	41.18%)	and	focal	or	tume-
afective	 in	16	cases	 (16/34,	47.06%).	These	 lesions	showed	
hyperintensity	on	T2-weighted	and	FLAIR	images.
Parenchymal	 cysts	 (also	 known	as	 cyst-like	white	matter	
lesions)	were	found	in	22	cases	 (22/34,	64.71%),	 they	were	
round	or	oval	with	sharp	contours,	with	signal	 intensities	
in	T1,	T2WI	and	FLAIR	 sequences	 corresponding	 to	 cere-
brospinal	fluid	(CSF).	Fig	3.
The	cysts	were	 located	 in	the	periventricular	regions	near	
the	frontal	and	occipital	horns	or	in	deep	white	matter	near	
the	lateral	ventricular	body.
Figure 1.  Cerebral cortical tubers. FLAIR sequence showed hyper- and 
hypointense lesions. A – axial image shows hyperintense 
signal of cortical tubers. B – axial and coronal images show 
hypointense signal of cortical tubers.
B B
A A
59
Pol J Radiol, 2007; 72(2): 56-64 Analysis of MRI spectrum of brain abnormalities...
Contrast	enhancement	was	noticed	 in	 some	 focal,	nodular	
white	matter	 lesions.	No	 enhancement	 of	 the	 cystic	walls	
was	seen.
Subependymal nodules – SENs
We	defined	SENs	as	lesions	that	originate	from	the	ventric-
le	walls	and	penetrated	into	the	ventricle.
Subependymal	nodules	were	detected	in	80	of	the	92	patients	
(86.96%).	They	were	 located	 on	 the	 lateral	 ventricles	 in	 all	
80	patients	and	at	the	foramen	of	Monro	in	45	cases	(45/80,	
56.25%).	They	were	bilateral	 in	 65	patients	 (65/80,	 81.25%)	
and	unilateral	in	15	(15/80,	18.75%).	SENs	were	1-10	mm	in	
diameter	and	did	not	cause	obstructive	hydrocephalus.	The	
number	 of	 subependymal	 nodules	 varied	 from	1	 to	 10	 per	
patient.	They	showed	variably	low	signal	intensity	on	T2WI	
and	they	were	isointense	to	white	matter	on	T1WI.	Fig	4.
Most	of	subependymal	nodules	manifested	nodular	or	ring-
like	enhancement.
Subependymal giant cell astrocytomas – SGCAs
We	 recognized	 subependymal	 giant	 cell	 astrocytomas	 if	
they	were	located	near	foramen	of	Monro,	were	larger	then	
12mm	in	diameter,	caused	obstructive	hydrocephalus,	their	
signal	intensity	was	heterogenous	and	they	revealed	strong	
contrast	enhancement.
We	found	SGCA	in	11	from	92	of	our	patients	 (11.96%);	 in	
one	case	SGCA	was	located	bilaterally.	Age	of	patients	was	
5	to	14	years	(mean	9.6	years).	All	SGCAs	were	located	near	
the	 foramen	of	Monro;	 5	 tumors	were	 located	 on	 the	 left	
and	7	on	the	right	side.	Fig	5
All	tumors	caused	obstructive	hydrocephalus,	and	contrast	
enhancement	was	observed	in	all	cases.
The associated structural brain abnormalities were 
noticed as follows:
–		Enlargement	 of	 lateral	 ventricles	 (without	 SGCAs)	 in	 8	
patients	–	(8/92,	8.69	%)
–		Cerebellar	atrophy	in	6	patients	–	(6/92,	6.52%)
–		Cortical	dysplasia	in	5	patients	–	(5/92,	5.43%)
–		Partial	 agenesis	 of	 the	 corpus	 callosum	 in	 3	 patients	
–	(3/92,	3.26%)
–		Aneurysm	of	carotid	artery	in	one	patient	–	(1/92,	1.09%)
–		Venous	malformation	in	one	patient	–	(1/92,	1.09%).
Discussion
MRI	 is	 the	method	 of	 choice	 for	 investigating	TSC	 and	 it	
is	more	 sensitive	 than	CT	 in	 identifying	 tubers	 and	white	
matter	abnormalities	[8,	9].	
Figure 2.  Cerebellar tubers. Coronal FLAIR and T1WI pre- and after 
contrast injection. A – Coronal FLAIR sequence shows 
cerebellar tuber with atrophy. B – Transverse T1-weighted 
image shows hypointense signal of two cerebellar tubers. 
Image after gadolinium injection – only one cerebellar tuber 
shows contrast enhancement.
A
B
B
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Cortical	tubers	are	the	most	characteristic	lesions	of	tube-
rous	sclerosis	complex,	they	are	detected	in	88-95%	of	the	
patients,	mostly	 in	 the	 cerebral	 hemispheres	 [8,	10,	11].	
Cerebral	 cortical	 tubers	 are	 generally	 multiple,	 bilate-
ral	 and	mostly	 located	 in	 the	 frontal	 and	 parietal	 cere-
bral	 lobes.	 Sometimes	 they	may	 be	 singular	 [12].	 They	
can	 occur	without	 cerebellar	 tubers,	 but	 the	 latter	 are	
not	 observed	 in	 the	 absence	 of	 cerebral	 tubers;	 cerebel-
lar	 tubers	may	 associate	with	 parenchymal	 volume	 loss	
[8,	13,	14].	
Tubers	 represent	 focal	 hamartomatous	 regions	 of	 dis-
organized	 cortical	 lamination	 [15].	 Histologically,	 they	
are	 characterized	 as	 atypical	 giant	 astrocytes,	 abnormal	
	maloriented	neurons,	 an	 increase	 in	number	 of	 astrocytic	
nuclei	 and	 lack	 of	 the	 normal	 six-layered	 lamination	 of	
the	cortical	gray	matter.	Cortical	tubers	are	of	various	size	
(from	millimeters	to	several	centimeters)	and	cause	distor-
tion	 of	 the	normal	 cortical	 architecture	with	 gyral	 defor-
mation	[3,	8,	16].	
In	 our	 study,	 the	 distribution	 pattern	 for	 cortical	 tubers	
involved	predominantly	 frontal	 and	parietal	 lobes	 similar	
to	that	reported	previously	 [9,17,18]. Temporal	and	occipi-
tal	 lobes	 showed	 the	 lowest	occurrence	of	 lesions.	We	did	
not	find	predominance	of	tubers	in	the	left	dominant	hemi-
sphere	 as	was	 observed	 in	paper	 published	by Baron	 and	
Barkovich	[19]. 
In	MR	 imaging	 a	 tuber	was	 defined	 as	 a	 lesion	 affecting	
the	cortical	gray	matter	and	adjacent	white	matter	with	an	
inner	core	hyperintense	to	grey	and	white	matter	on	FLAIR	
images.	Cortical	 tubers	 and	white	matter	 lesions	 are	 best	
seen	on	T2-weighted	images,	especially	on	FLAIR	sequence	
as	hyperintense	areas,	on T1-weighted	as	iso-	or	low-signal	
lesion	[20,	21]. 
Some	tubers	may	undergo	cellular	degeneration	into	cystic	
lesions,	the	inner	part	of	tubers	may	show	signal	intensity	
that	is	isointense	to	the	cerebrospinal	fluid	on	all	sequences	
[6,	8,	21,	22]. 
Figure 3.  White matter lesions: radial bands, parenchymal cyst, 
focal lesion. A – Transverse FLAIR sequence shows 
parenchymal cyst and typical cerebral tubers. B – Transverse 
FLAIR sequence shows radial bands (parenchymal cyst, 
subependymal nodules and cerebral tubers are also seen) 
C – Transverse FLAIR sequence shows radial bands and 
focal white matter lesion.
A B
C
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Most	 tubers	 in	 this	 study	 of	 a	 predominantly	 pediatric	
population	(average	age,	9.3	years)	had	signal	intensity	(on	
T2WI	and	FLAIR	images)	characteristics	 identical	 to	those	
in	previous	reports	[10,	23].
Although	in	19	patients	 (19/89,	21.35%)	we	found	cyst-like	
cortical	 tubers	with	hypointense	 signal	 on	FLAIR	 images,	
these	 findings	were	 presented	 in	 our	 previous	 published	
paper	[6].
Enhancement	of	cerebral	tubers	following	contrast	admini-
stration	has	been	reported	in	less	than	5%	of	patients	[8].
None	 of	 supratentorial	 tubers	 in	 our	 series	 revealed	 con-
trast	enhancement.
Cerebellar	localization	is	less	frequent	and	occurs	in	10-15%	
of	 patients	 according	 to	 previous	 data	 [3,	8,	11,	24].	Only	
Mart-Bonmati	 [14]	 observed	 cerebellar	 lesions	 in	 44.1%	
of	 patients	 (15/34).	 In	 our	 study	 cerebellar	 findings	were	
disclosed	in	12	of	92	patients	(13.04%).
After	gadolinium	administration	they	show	variable	enhan-
cement,	 some	 enhance	mildly,	 but	 some	of	 them	may	not	
enhance	at	all.
In	 our	 studies	 we	 noticed	 wegde-shaped	 enhancement	
of	 11	 cerebellar	 tubers,	 but	 10	 cerebellar	 tubers	 did	 not	
enhance.	Sener	[24]	presented	four	patients	with	cerebellar	
tubers,	 3	 of	 them	had	 contrast	 injection	 and	none	 of	 the	
tubers	enhanced.	Girard	[25 investigated	21	patients,	all	of	
them	had	 gadolinium	 injection,	 only	 two	patients	 presen-
ted	enhancement	of	cerebellar	tubers.	Castillo	[26]	reported	
one	case	with	three	different	sites	of	contrast	enhancement	
in	the	cerebellum.	He	observed	gyriform	enhancement	of	a	
cerebellar	 tuber;	 this	 type	of	 enhancement	was	not	 found	
in	our	study.
White	 matter	 abnormalities	 were	 defined	 as	 areas	 of	
abnormal	signal	intensity	in	the	white	matter	subjacent	to	
a	tuber	or	nodule,	linear	(i.e.	radial	band)	or	wedge-shaped	
lesions	extending	from	the	ventricular	surface	to	a	cortical	
tuber	and	deep	white	matter	cysts	[27].	
Signal	 intensity	 of	 white	 matter	 lesions	 correlated	 with	
histopathologic	features,	which	are	nearly	identical	in	both	
Figure 4.  Subependymal nodules. A – Axial T1WI image before and B, 
C – after gadolinium injection.
A B
C
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cortical	 tubers	 and	 white	 matter	 abnormalities	 (gliosis,	
myelinization	defects,	heterotopic	giant	cells)	[3].	
Pathologic	 examination	 showed	 giant	 cells	 following	 the	
path	of	neuronal	migration	tracts	[8,	27].
Radial	bands	are	thought	to	represent	a	disturbance	in	nor-
mal	migration	 of	 neural	 progenitor	 cells	 from	 the	 ventri-
cular	 germinal	matrix	 to	 the	 cerebral	 cortex	during	brain	
development.
Visualization	of	radial	bands	may	be	helpful	 in	distinguis-
hing	TSC	from	demyelinating	lesions,	infections	or	ischemic	
changes	[27].	
White	matter	 lesions	have	been	 reported	 less	 frequently	 on	
MR	images.	DiMario	[21]	reported	white	matter	lesions	in	30%	
of	TSC	patients,	in	study	presented	by	Shepard	et	al.	[4]	21%	of	
patients	showed	linear	or	curvilinear	lesions	in	the	white	mat-
ter,	extending	from	subependymal	nodules	to	cortical	tubers.
Girard	et	al.	[25]	found	white	matter	lesions	in	19	of	the	21	
examined	patients.
Only	in	paper	published	by	Herron	et	al.	[11]	white	matter	
lesions	were	visible	in	90%	of	patients.	
We	 found	white	 matter	 abnormalities	 in	 34	 of	 92	 (37%)	
patients.
In	our	 studies	T2WI	and	FLAIR	 sequences	 showed	hyper-
intense	 radially	 oriented	 white	 matter	 bands	 extending	
from	 the	periventricular	 region	 to	 the	 cortical	 tubers	 and	
probably	corresponding	to	 the	so-called	migration	 lines	or	
wedge-shaped	lesions	[3,	28].	
Approximately	 12%	of	 these	 lesions	 show	contrast	 enhan-
cement	[3].	We	noticed	contrast	enhancement	in	6	patients	
(6/34,	17.65%).
Cystic	white	matter	lesions	have	recently	been	described	as	
a	feature	of	tuberous	sclerosis	[22].
22	patients	in	our	sample	presented	parenchymal	cysts;	the	
origin	of	 the	cysts	 is	unknown	and	might	represent	enlar-
ged	 Virchow-Robin	 perivascular	 spaces,	 neuroepithelial	
cysts,	or	even	the	cystic	degeneration	of	dysplastic	 lesions	
of	white	matter	[22].	The	cysts	are	most	frequently	located	
in	 the	perivascular	white	matter	 and	 they	are	part	 of	 the	
spectrum	of	TSC	lesions.
According	 to	 previously	 published	 papers	we	 also	 found	
cyst-like	 lesions	 predominantly	 located	 in	 the	 deep	white	
matter	and	near	frontal	and	occipital	horns	[22,	23,	29].	In	
our	patients	no	cysts	were	noticed	within	corpus	callosum,	
unlike	 the	 studies	 by	Van	Tassel	 et	 al.	 [22]	who	 reported	
two	patients	with	cysts	in	that	location.
Subependymal	 nodules	 and	 SEGAs	 are	 defined	 by	 their	
anatomic	 location	 adjacent	 to	 the	 ventricles	 of	 the	 brain	
and	 they	 are	histologically	 benign	 lesions.	The	distinction	
between	subependymal	nodules	and	SGCAs	is	made	on	the	
basis	of	size,	although	there	are	possibly	unknown	genetic	
changes	that	drive	the	production	of	SGCAs	from	subepen-
dymal	nodules	[30].	
Subependymal	 nodules	 (SENs)	 were	 defined	 as	 small	
nodular	 lesions	 originating	 from	 the	wall	 of	 the	 lateral	
ventricles	 and	 protruding	 into	 the	 ventricular	 lumen.	
They	 are	 typically	 found	 along	 the	 ventricular	 sur-
face	 of	 lateral	 ventricle	 (near	 the	 sulcus	 terminalis)	
Figure 5.  Subependymal giant cells astrocytoma. A – Axial T1WI pre- and B – post-contrast images show bilateral tumors.
A B
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posterior	 to	 the	 foramen	 of	Monro.	However,	 they	 can	
also	be	seen	elsewhere	in	the	ventricular	system.
Subependymal	 nodules	 are	 observed	 in	 90%-95%	 of	 all	
cases	 [8,	10,	11].	 We	 revealed	 SENs	 in	 80	 from	 92	 our	
patients	(87%)
Histologically	the	nodules	are	composed	of	giant	cells	with	
glial	 and	neural	 features	 and	 can	 contain	many	vascular	
elements	[3].	Calcification	commonly	increases	with	age.
T1	 and	T2-weighted	MR	 images	 are	used	 to	 identify	 sub-
ependymal	 nodules	 which	 protrude	 into	 the	 ventricle.	
Subependymal	nodules	compared	with	cortical	gray	matter	
are	often	isointense	to	hyperintense	on	T1WI	and	isointen-
se	 to	 hypointense	 (because	 of	 the	 calcification)	 on	T2WI.	
30-80%	of	 subependymal	nodules	 show	contrast	 enhance-
ment	[8].	
SENs	 may	 undergo	 neoplastic	 change	 to	 subependymal	
giant	cell	astrocytoma	in	approximately	8%	of	patients	[31].	
All	 SENs	 that	we	 found	were	 located	 in	 lateral	 ventric-
les,	 no	nodules	were	 found	 in	 third	 and	 fourth	ventricle.	
According	to	previous	papers	they	showed	the	same	signal	
intensity	while	most	of	them	were	characterized	by	nodu-
lar	or	ring-like	enhancement	[8,	10,	11].	
Subependymal	 giant	 cell	 astrocytomas	 are	 the	most	 com-
mon	brain	tumors	associated	with	TSC.	Most	often	they	are	
located	near	 the	 foramen	of	Monro,	 less	 frequently	 in	 the	
ependymal	 tissue	 near	 the	 atria,	 temporal	 horns	 or	 very	
rarely	 in	 the	cerebral	hemisphere.	Their	enlargement	usu-
ally	 leads	 to	 CSF	 flow	obstruction.	The	 incidence	 in	TSC	
is	 about	 5-10%	 [8,	32]	 or	 up	 to	 15%	 according to	Herron	
et	al.	[11].
The	peak	age	of	occurrence	is	in	patients	aged	8-18	years;	
in	our	study	patients	were	aged	5–13	(average,	9.1	years).
It	is	believed	that	subependymal	giant	cell	tumors	originate	
from	subependymal	nodules.
On	MR	 imaging	 SGCAs	 resembles	 SENs,	 except	 that	 the	
tumors	are	larger,	usually	heterogenous,	cause	hydrocepha-
lus	and	show	enhancement	after	contrast	administration.
We	 found	 SGCA	 in	 11	 from	 92	 of	 our	 patients	 (11.96%).	
In	 all	 cases	 the	 tumors	were	 located	near	 the	 foramen	of	
Monro,	in	1	patient	bilaterally.	
Contrast	 enhancement	 of	 brain	 abnormalities	 in	 TSC	
patients	indicates	lack	of	an	intact	blood-brain	barrier.
Gadolinium	administration	is	not	useful	in	detecting	corti-
cal	 tubers,	white	matter	 lesions	 and	 subependymal	nodu-
les,	although	may	help	in	detection	of	SGCA;	however,	the	
parameters	of	size	 (>	12	mm),	growth	over	the	time,	 loca-
tion	 and	potential	 for	 obstructive	 hydrocephalus	 are	 also	
important	for	a	presumptive	diagnosis	of	these	tumors.
Enlargement	 of	 lateral	 ventricles	 is	 usually	 caused	 by	
atrophy	or	repeated	seizures	associated	with	hypoxia,	and	
it	was	observed	 in	25%	cases	 in	 the	study	by	Braffman	et	
al.	[8].	In	our	group	of	patients	mild	ventriculomegaly	was	
found	only	in	18	patients	(18/92,	19.57%)
Cerebellar	 tissue	 atrophy	 was	 also	 observed	 in	 a	 small	
number	of	our	patients	(only	6/92,	6,52%)	similarly	to	data	
in	literature;	Marti-Bonmati	et	al.	[14]	observed	parenchy-
mal	volume	loss	in	4	of	34	children	(11.8%).	
Cortical	dysplasia	was	detected	 in	5	of	 our	patients	 (5/92,	
5.43%),	 and	according	 to	 the	 articles	 published	previously	
cortical	dysplasia	in	those	cases	also	encompased	large	seg-
ment	of	cortex	[3,	28,	33].	
We	 did	 not	 find	 hemimegalencephaly	 or	 schizencephaly	
associated	with	TSC.	It	is	a	very	uncommon	finding	in	this	
disease.	Up	to	now	only	two	cases	with	schizencephaly	 in	
TSC	have	been	reported	[28,	33].	
According	 to	 our	 knowledge	 7	 patients	 with	 hemimega-
lencephaly	were	reported	previously,	one	of	 them	was	the	
focal	hemimegalencephaly	[34,	35,	36,	37,	38,	39].
Partial	agenesis	of	corpus	callosum	has	been	reported	befo-
re	[3,	28,	40].	
We	also	found	partial	but	not	complete	agenesis	of	corpus	
callosum	in	3	patients.	
Vascular	 lesions	 (stenoses,	 ectasia,	 aneurysm)	 are	 not	
common;	 they	 have	 been	 found	 predominantly	 in	 perip-
heral	 vessels.	 Intracerebral	 localization	 of	 aneurysms	 in	
TSC	patients	 is	extremely	rare;	the	 internal	carotid	artery	
is	 involved	most	 commonly	 (60%).	According	 to	 our	 kno-
wledge,	 only	 17	 TSC	 patients	 with	 intracranial	 aneury-
sms	have	been	previously	described,	one	of	 them	was	our	
patient	(9	years-old	boy)	[7,	41,	42]. 
In	one	case	we	also	found	venous	malformation	located	in	
the	left	frontal	lobe	in	a	14-year-old	girl.	
Conclusions
This	 study	presents	 central	 nervous	 system	manifestation	
of	various	abnormalities	in	patients	with	tuberous	sclerosis	
complex.
We	would	 like	to	underline	the	 importance	of	proper	MRI	
examinations	with	different	sequences	and	planes	for	suc-
cessful	 diagnosis	 and	 imaging	 of	 various	 brain	 lesions	 in	
tuberous	sclerosis	patients.
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